logo-loader

Baxalta shares up as it gets European go-ahead for heamophilia A treatment

Last updated: 13:01 13 Nov 2015 EST, First published: 08:01 13 Nov 2015 EST

shutterstock_260218637_564625fb23494
The green light comes after a Phase II/III open-label clinical trial, which evaluated the drug's efficacy and safety and showed positive results..

Shares in global pharma firm Baxalta (NYSE:BXLT), which has been pursued by British group Shire (LON:SHP) nudged higher after it received European marketing permission to give its OBIZUR drug to adults who suffer from acquired heamophilia A.

The green light comes after a Phase II/III open-label clinical trial, which evaluated the drug's efficacy and safety and showed positive results.

OBIZUR can treat bleeding in adult patients with acquired heamophilia, caused by antibodies to Factor VIII, a rare but life-threatening bleeding disorder.

The group's vice president of haematology, Brian Goff, told investors in a statement: “Gaining Marketing Authorization for this first recombinant porcine option for acquired haemophilia in Europe reflects Baxalta’s commitment to improving patient lives.”

Last week the US biotech reported better-than-expected results for its third quarter.

In its third quarter to end September, Baxalta posted a profit of US$309mln, up from US$246 million a year earlier.

Net sales grew 7.2% to $1.6 billion, which was better than analysts had expected.

Baxalta specialises in making drugs that treat rare bleeding disorders.

Earlier this year, Shire made an unsolicited $30.6 billion takeover bid, which was rebuffed.

On Friday, Baxalta shares added 2.35% to stand at US$34.03.

Rush Rare Metals Advances Two Key Projects: Uranium in Wyoming and Niobium...

Rush Rare Metals CEO Peter Smith joined Steve Darling from Proactive to share news about the mineral exploration company's focus on its Boxi Property in Quebec and the Copper Mountain Project in Wyoming. The company recently announced the staking of the Knob claims in Wyoming, comprising 52...

8 minutes ago